Dr Mike Yeadon has a degree in biochemistry and toxicology and a research-based PhD in respiratory pharmacology. He has spent over 30 years leading new medicines research in some of the world’s largest pharmaceutical companies, leaving Pfizer in 2011 as Vice President & Chief Scientist for Allergy & Respiratory. That was the most senior research position in this field in Pfizer. Since leaving Pfizer, Dr Yeadon has founded his own biotech company, Ziarco, which was sold to the worlds biggest drug company, Novartis, in 2017.
Uniéndose en todo el mundo con la integridad y la acción correcta.